Meredith Owen is a leader in late-phase clinical trial operations, focusing on diabetes, obesity, and metabolic diseases. With a PhD in Cellular and Integrative Physiology from Indiana University School of Medicine, Meredith conducted research on cardiovascular physiology related to diabetes and obesity. They have over 10 years of project management experience, including roles as Director of Clinical Development at Eli Lilly and Study Director at Covance. In addition to their scientific expertise, Meredith emphasizes quality and innovation in trial execution.
Location
Indianapolis, United States
This person is not in any teams
This person is not in any offices